We demonstrated that, in contrast to classical opioid receptors, ACKR3 doesn't bring about classical G protein signaling and is not modulated via the classical prescription or analgesic opioids, including morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists which include naloxone. Instead, we recognized that LIH383, an ACKR3-selective subnanomolar https://alexandrec792uoj6.hyperionwiki.com/user